These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2827098)

  • 1. Heritable fraction of unilateral Wilms tumor.
    Li FP; Williams WR; Gimbrere K; Flamant F; Green DM; Meadows AT
    Pediatrics; 1988 Jan; 81(1):147-9. PubMed ID: 2827098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A French genetic and epidemiologic study on nephroblastoma: preliminary results].
    Bonaïti-Pellié C; Chompret A; Tournade MF; Zucker JM; Lemerle J
    Bull Cancer; 1988; 75(1):131-3. PubMed ID: 2833963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumor in five cousins.
    Cordero JF; Li FP; Holmes LB; Gerald PS
    Pediatrics; 1980 Nov; 66(5):716-9. PubMed ID: 6253867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple pathways to Wilms tumor: how much is genetic?
    Pritchard-Jones K; Vujanic G
    Pediatr Blood Cancer; 2006 Sep; 47(3):232-4. PubMed ID: 16830319
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of Wilms' tumor: insights into normal and abnormal renal development.
    Pelletier J
    Can J Oncol; 1994 Apr; 4(2):262-72. PubMed ID: 8004410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management and biological behavior of Wilms tumor.
    Coopes MJ
    Int Rev Exp Pathol; 1994; 35():149-76. PubMed ID: 7860189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of clonality of nephroblastomas in patients with Wilms tumors].
    Gürtl B; Ratschek M; Harms D; Jänig U; Böcker W; Poremba C; Höfler G
    Verh Dtsch Ges Pathol; 2000; 84():162-3. PubMed ID: 11217436
    [No Abstract]   [Full Text] [Related]  

  • 14. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
    Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
    Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the clinical and molecular genetics of Wilms' tumor.
    Grundy P; Coppes M
    Med Pediatr Oncol; 1996 Nov; 27(5):394-7. PubMed ID: 8827064
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic events and molecular biology of Wilms' tumor].
    Navajas Gutiérrez A; Pérez-Saracho Taramona M
    An Esp Pediatr; 1997 Feb; 46(2):105-8. PubMed ID: 9157794
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetics of Wilms' tumor.
    Coppes MJ; Egeler RM
    Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.